Nonadherence to anti-TNF therapy predicts clinical outcomes in outpatients with inflammatory bowel disease: results from a prospective multicentre study

被引：0
|
作者：
van der Have, M. [1 ]
Oldenburg, B. [1 ]
Kaptein, A. A. [2 ]
Jansen, J. M. [3 ]
Scheffer, R. C. [4 ]
van Tuyl, S. A. [5 ]
van der Meulen-de Jong, A. E. [6 ]
Pierik, M. [7 ]
Siersema, P. D. [1 ]
van Oijen, M. G. [1 ,8 ]
Fidder, H. H. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[2] Leiden Univ, Med Ctr, Sect Med Psychol, Leiden, Netherlands
[3] Onze Lieve Vrouw Hosp, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[4] Jeroen Bosch Hosp, Dept Gastroenterol & Hepatol, Shertogenbosch, Netherlands
[5] Diakonessen Hosp, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[6] Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Leiden, Netherlands
[7] Maastricht Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-6200 MD Maastricht, Netherlands
[8] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP043
引用
收藏
页码：S52 / S53
页数：2
相关论文
共 50 条
  • [31] Inflammatory bowel disease as a paradoxical effect of anti-TNF alpha therapy
    Iriarte, Ainara
    Zaera, Celia
    Bachiller-Corral, Javier
    Lopez-Sanroman, Antonio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (02): : 117 - 121
  • [32] Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy
    Khan, Nabeel
    Asim, Hamna
    Lichtenstein, Gary R.
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (12) : 1699 - 1708
  • [33] Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease
    Frank I. Scott
    Gary R. Lichtenstein
    Current Treatment Options in Gastroenterology, 2014, 12 (1) : 59 - 75
  • [34] Precision Dosing of Anti-TNF Therapy in Pediatric Inflammatory Bowel Disease
    Samuels A.
    Whaley K.G.
    Minar P.
    Current Gastroenterology Reports, 2023, 25 (11) : 323 - 332
  • [35] Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy
    Miranda-Bautista, Jose
    de Gracia-Fernandez, Celia
    Lopez-Ibanez, Maria
    Barrientos, Maria
    Gallo-Molto, Alejandra
    Gonzalez-Arias, Marina
    Gonzalez-Gil, Casilda
    Diaz-Redondo, Alicia
    Marin-Jimenez, Ignacio
    Menchen, Luis
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (07) : 2130 - 2135
  • [36] ANTI-TNF THERAPY INDUCED ARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Reilly, Elizabeth
    Edwards, Cathryn
    Mackay, Kirsten
    RHEUMATOLOGY, 2015, 54 : 94 - 94
  • [37] Chronic Inflammatory Bowel Disease: New Markers for Anti-TNF Therapy?
    Franke, Katharina
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (01): : 8 - 8
  • [38] Microreinduction of injectable anti-TNF therapy in Patients with Inflammatory Bowel Disease
    Ligler, Robin
    Horst, Sara
    Duley, Caroline
    Wagnon, Julianne
    Beaulieu, Dawn
    Schwartz, David
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S41 - S42
  • [39] Ustekinumab and Anti-TNF Combination Therapy in Patients with Inflammatory Bowel Disease
    Yzet, Clara
    Dupas, Jean-Louis
    Fumery, Mathurin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (05): : 748 - 749
  • [40] Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy
    Miranda-Bautista, Jose
    de Gracia, Celia
    Lopez-Ibanez, Maria
    Barrientos, Maria
    Marin-Jimenez, Ignacio
    Diaz-Redondo, Alicia
    Menchen, Luis
    GASTROENTEROLOGY, 2014, 146 (05) : S577 - S577
12345